TD Asset Management Inc. raised its stake in shares of Dentsply International Inc. (NASDAQ:XRAY) by 42.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 465,488 shares of the company’s stock after buying an additional 139,460 shares during the period. TD Asset Management Inc.’s holdings in Dentsply International were worth $27,664,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Checchi Capital Advisers LLC boosted its stake in shares of Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock valued at $125,000 after buying an additional 41 shares during the last quarter. Contravisory Investment Management Inc. boosted its stake in Dentsply International by 8.9% in the third quarter. Contravisory Investment Management Inc. now owns 3,108 shares of the company’s stock valued at $185,000 after buying an additional 254 shares in the last quarter. Global X Management Co. LLC boosted its stake in Dentsply International by 110.1% in the second quarter. Global X Management Co. LLC now owns 3,169 shares of the company’s stock valued at $197,000 after buying an additional 1,661 shares in the last quarter. Evercore Wealth Management LLC boosted its stake in Dentsply International by 12.6% in the second quarter. Evercore Wealth Management LLC now owns 3,204 shares of the company’s stock valued at $199,000 after buying an additional 358 shares in the last quarter. Finally, Mizuho Asset Management Co. Ltd. boosted its stake in Dentsply International by 170.4% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 3,228 shares of the company’s stock valued at $200,000 after buying an additional 2,034 shares in the last quarter. 93.48% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Dentsply International (NASDAQ:XRAY)

Shares of Dentsply International Inc. (NASDAQ:XRAY) traded down 1.39% during midday trading on Wednesday, reaching $59.63. 273,040 shares of the company traded hands. The stock has a 50 day moving average price of $59.20 and a 200 day moving average price of $61.02. Dentsply International Inc. has a 1-year low of $53.43 and a 1-year high of $65.83.

Dentsply International (NASDAQ:XRAY) last announced its earnings results on Friday, November 4th. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.03. Dentsply International had a return on equity of 8.04% and a net margin of 11.15%. The firm had revenue of $954.20 million for the quarter, compared to analyst estimates of $967.68 million. During the same quarter last year, the firm posted $0.66 EPS. The business’s revenue was up 47.0% on a year-over-year basis. Equities research analysts expect that Dentsply International Inc. will post $2.77 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This report was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2016/11/30/dentsply-international-inc-xray-shares-bought-by-td-asset-management-inc.html.

Several equities research analysts have recently commented on the stock. Zacks Investment Research cut shares of Dentsply International from a “hold” rating to a “sell” rating in a research report on Wednesday, November 2nd. JPMorgan Chase & Co. assumed coverage on shares of Dentsply International in a research report on Thursday, September 22nd. They issued a “neutral” rating and a $65.00 target price for the company. Barrington Research cut shares of Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Morgan Stanley raised shares of Dentsply International from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $65.00 to $69.00 in a research report on Tuesday, November 1st. They noted that the move was a valuation call. Finally, Jefferies Group reaffirmed a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $67.33.

In other news, VP Rainer Berthan sold 5,000 shares of the stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total transaction of $305,600.00. Following the transaction, the vice president now owns 34,370 shares in the company, valued at approximately $2,100,694.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO James G. Mosch sold 30,400 shares of the stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $60.93, for a total value of $1,852,272.00. Following the transaction, the chief executive officer now owns 75,283 shares in the company, valued at approximately $4,586,993.19. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Dentsply International Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.